Capricor Therapeutics rStock RCAPR
RCAPR
5.930
$
0.68 %
Change 24h
Market Cap
$ 3223.8
Volume 24h
$ 6.350
Circulating Supply
543
Total Supply
770
RCAPR
$
| # | Exchange | Pair | Price | Volume 24h |
|---|
Description
Capricor Therapeutics is a clinical-stage biotechnology company focused on developing innovative cell and exosome-based therapies. The company's R&D pipeline primarily targets the treatment of rare diseases, with a specific focus on advancing the clinical validation and commercialization of drugs for Duchenne muscular dystrophy (DMD).